ACLX

Arcellx
ACLX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.25B
EV
$2.74B
Shares Outstanding
59.95M
Beta
0.34

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$112.47
P/E 2025E
-
P/Revenue 2025E
52.01x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Arcellx, Inc.

gainify
ACLX

Arcellx, Inc.

ACLX

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company’s lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 ...

Sector

Healthcare

Industry

Biotechnology

CEO

Elghandour, Rami

Employees

163

IPO Date

2022-02-04

Headquarters

800 Bridge Parkway, Redwood City, California, 94065, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on Instagram
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.